2. Others
  3. mRNA
  4. Firefly Luciferase mRNA

Firefly Luciferase mRNA is a reporter mRNA that can be transfected into cells to express firefly luciferase protein. Firefly Luciferase mRNA induces cytotoxicity in cancer cells at low concentrations. In cancer cells, the expression level of luciferase shows a non-linear relationship with the dose of Firefly Luciferase mRNA. When combined with the H2S-responsive bioluminescent probe (H-Luc), Firefly Luciferase mRNA enables bioluminescence-based detection of endogenous hydrogen sulfide in non-transgenic NAFLD cell models and NAFLD mouse models. Firefly Luciferase mRNA can be used in studies related to non-alcoholic fatty liver disease.

For research use only. We do not sell to patients.

Firefly Luciferase mRNA

Firefly Luciferase mRNA Chemical Structure

Size Price Stock Quantity
100 μg In-stock

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Firefly Luciferase mRNA Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Firefly Luciferase mRNA is a reporter mRNA that can be transfected into cells to express firefly luciferase protein. Firefly Luciferase mRNA induces cytotoxicity in cancer cells at low concentrations. In cancer cells, the expression level of luciferase shows a non-linear relationship with the dose of Firefly Luciferase mRNA. When combined with the H2S-responsive bioluminescent probe (H-Luc), Firefly Luciferase mRNA enables bioluminescence-based detection of endogenous hydrogen sulfide in non-transgenic NAFLD cell models and NAFLD mouse models. Firefly Luciferase mRNA can be used in studies related to non-alcoholic fatty liver disease[1][2].

In Vitro

Firefly Luciferase mRNA (0.02-4.60 μg/mL; 5 h treatment incubation, 48 h post-treatment measurement) transfection of Jurkat cells results in limited, non-linear luciferase expression and significant cytotoxicity, with cell viability dropping to 40-50% at high mRNA concentrations[1].
Firefly Luciferase mRNA (0.02-4.60 μg/mL; 5 h treatment incubation, 48 h post-treatment measurement) transfection of L-929 cells produces limited luciferase expression that peaks at 3 μg/mL mRNA before declining, with no associated cytotoxicity across tested concentrations[1].
Firefly Luciferase mRNA (0.02-4.60 μg/mL; 5 h treatment incubation, 48 h post-treatment measurement) transfection of HEK 293 T cells produces a strong, linear dose-dependent increase in luciferase expression across 0.02 to 4.60 μg/mL mRNA with no cytotoxicity, but exhibits high intra-group variability[1].
Firefly Luciferase mRNA (50 ng; 24 h) delivered via 4A3-SCC-PH LNPs to nontransfected MDA-MB-231 cells successfully produces functional firefly luciferase, enabling sensitive detection of endogenous H2S via H-Luc with a 68-fold increase in bioluminescence intensity relative to untreated cells[2].
Firefly Luciferase mRNA (50 ng; 24 h) delivered via 4A3-SCC-PH LNPs to nontransfected IGROV-1 cells successfully produces functional firefly luciferase, enabling sensitive detection of endogenous H2S via H-Luc[2].
Firefly Luciferase mRNA (50 ng; 24 h) delivered via 4A3-SCC-PH LNPs to oleic acid-induced NAFLD AML-12 cells successfully produces functional firefly luciferase, enabling detection of elevated endogenous H2S with a 3.7-fold higher bioluminescence intensity relative to normal AML-12 cells[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Firefly Luciferase mRNA Related Antibodies
In Vivo

Firefly Luciferase mRNA-loaded 4A3-SCC-PH LNPs (0.1 mg/kg; i.v.; single dose) enables bioluminescence imaging of endogenous H2S in NAFLD mouse livers, with NAFLD mice showing 28-fold higher liver bioluminescence intensity than normal mice[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6 (female, 6-8 weeks old, NAFLD induced by 60% fat high-fat diet and intraperitoneal injection of dexamethasone sodium phosphate at 100 mg/kg every 2 days for 7 days)[2]
Dosage: 0.1 mg/kg
Administration: i.v.; single dose
Result: Exhibited 28-fold higher bioluminescence intensity in the liver compared to normal mice.
Detected bioluminescence signals within the first 5 minutes after H-Luc injection, reached maximum intensity at 10 minutes, and remained stable for at least 30 minutes.
Showed intense bioluminescence signals in the liver and spleen via ex vivo imaging.
Had liver bioluminescence signals suppressed by 19-fold after pretreatment with AOAA.
Appearance

Liquid

Color

Colorless to light yellow

Shipping

Shipping with dry ice.
Storage

-80°C
Purity & Documentation

Purity: 90%

SDS (251 KB)

COA (231 KB)

Handling Instructions (2659 KB)
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Firefly Luciferase mRNA Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Firefly Luciferase mRNAmRNAmessenger RNAembryonic kidney cellsJurkat cellscancer cellsfirefly luciferaseC57BL/6 miceL-929 cellshepatocytesconnective tissue cellsnonalcoholic fatty liver diseaseHEK 293 T cellsInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Firefly Luciferase mRNA
Cat. No.:
HY-174790
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (251 KB) Français - FR (251 KB) Deutsch - DE (251 KB) Norwegian - NO (251 KB) Español - ES (251 KB) Swedish - SV (251 KB) Italian - IT (251 KB) Korean - KR (251 KB) Portuguese - PT (251 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.